欢迎来到麦多课文档分享! | 帮助中心 海量文档,免费浏览,给你所需,享你所想!
麦多课文档分享
全部分类
  • 标准规范>
  • 教学课件>
  • 考试资料>
  • 办公文档>
  • 学术论文>
  • 行业资料>
  • 易语言源码>
  • ImageVerifierCode 换一换
    首页 麦多课文档分享 > 资源分类 > PPT文档下载
    分享到微信 分享到微博 分享到QQ空间

    ANTIHYPERTENSIVES, DIURETICS, ANTICOAGULANTS .ppt

    • 资源ID:378454       资源大小:301.50KB        全文页数:100页
    • 资源格式: PPT        下载积分:2000积分
    快捷下载 游客一键下载
    账号登录下载
    微信登录下载
    二维码
    微信扫一扫登录
    下载资源需要2000积分(如需开发票,请勿充值!)
    邮箱/手机:
    温馨提示:
    如需开发票,请勿充值!快捷下载时,用户名和密码都是您填写的邮箱或者手机号,方便查询和重复下载(系统自动生成)。
    如需开发票,请勿充值!如填写123,账号就是123,密码也是123。
    支付方式: 支付宝扫码支付    微信扫码支付   
    验证码:   换一换

    加入VIP,交流精品资源
     
    账号:
    密码:
    验证码:   换一换
      忘记密码?
        
    友情提示
    2、PDF文件下载后,可能会被浏览器默认打开,此种情况可以点击浏览器菜单,保存网页到桌面,就可以正常下载了。
    3、本站不支持迅雷下载,请使用电脑自带的IE浏览器,或者360浏览器、谷歌浏览器下载即可。
    4、本站资源下载后的文档和图纸-无水印,预览文档经过压缩,下载后原文更清晰。
    5、试题试卷类文档,如果标题没有明确说明有答案则都视为没有答案,请知晓。

    ANTIHYPERTENSIVES, DIURETICS, ANTICOAGULANTS .ppt

    1、ANTIHYPERTENSIVES, DIURETICS, ANTICOAGULANTS AND DYSLIPIDEMICS,PHARMACOLOGY NUR 3703 BY LINDA SELF,Hypertension,Hypertension common in US, up to 60 million afflicted Leads to MI, heart failure, stroke and renal disease Strong correlation with metabolic syndrome,Blood Pressure Classification accordin

    2、g to the JNC 7,Normal SBP or equal to 160 or DBP or equal to 100,Types of Hypertension,Essential or primaryetiology ?. Contributors include: salt sensitivity, insulin resistance, genetics, sleep apnea, environmental factors,others Secondaryrenal, adrenal, coarctation of the aorta, steroids, pregnanc

    3、y,BP review,Any condition that affects heart rate, stroke volume or peripheral vascular resistance affects arterial blood pressure Compensatory mechanisms to maintain balance between hypotension and hypertension,BP review,BP regulation operates in a negative feedback system Baroreceptors and chemore

    4、ceptors in the carotid arteries and aortic arch detect changes in arterial blood pressure and in pO2, pCO2 and H+. Increased BP results in increased stretch of vessels; activation of vagus and stimulation of medulla via sympathetic or parasympathetic pathways.,BP review,Normally, when the arterial b

    5、lood pressure is elevated Kidneys will excrete more fluid Fluid loss will result in decreased ECF volume and blood volume Decreased blood flow to the heart will reduce cardiac output Decreased CO reduces arterial blood pressure,BP review cont.,5. Vascular endothelium produces vasodilating substances

    6、 (nitric oxide, prostacyclin) which reduce blood pressure,Essential Hypertension,Activation of sympathetic nervous system causing prolonged vasoconstriction Activation of RAAS plays integral part as well In combination, mechanisms cause prolonged increased vascular resistance; this in turn results i

    7、n a thickening of vessel walls, less production of nitric oxide (vasodilator) and increased endothelin (increased vascular tone),Essential Hypertension,Also felt that hyperinsulinemia and insulin resistance cause endothelial dysfunction by enhanced oxygen free radical-mediated damage and decreased n

    8、itric oxide bioavailability. Also is an increased sympathetic response; results in increased vascular tone and constriction,Nonpharmacologic Management of Hypertension,Weight reduction Exercise Salt restriction in diet Stress reduction DASH eating plan Moderation in alcohol intake If systolic BP can

    9、not be maintained 140 systolic, tx.,Antihypertensive Drugs,Classes: Angiotensin converting enzyme inhibitors (ACEI) Angiotensin II Receptor Blockers Antiadrenergics Calcium channel blockers Diuretics Direct vasodilators Renin inhibitors,ACEIs,Block the enzymes that convert angiotensin I to angiotens

    10、in II (potent vasoconstrictor) Have action of vasodilation and decrease aldosterone production Inhibit breakdown of bradykinins (vasodilator) prolonging effect,ACEIs,Reverse remodeling of heart muscle and blood vessels Reno-protective Excellent for heart failure and hypertension Improve post-myocard

    11、ial infarction survival Used alone or in combination,ACEIs,Useful in heart failure as decrease peripheral vascular resistance, cardiac workload and ventricular remodeling Captopril is the prototype Low incidence of side effects Can cause cough or hypotension when first started,ACEIs,Can cause hyperk

    12、alemia Should never be used during pregnancy May not be as effective in African Americansmay add diuretic in this population to increase efficacy,ACEIs,Lotensin (benazepril) Capoten (captopril) Vasotec (enalapril) Zestril (lisinopril) Altace (ramipril) Aceon (perindopril),Angiotensin II Receptor Blo

    13、ckers (ARBs),Block effects of angiotensin II, compete with angiotensin II for tissue binding sites Block the receptors in brain, kidneys, heart, vessels and adrenal tissue,ARBs,Similar end results as seen with ACEIs Less likely to cause hyperkalemia Persistence of cough is rare Prototype is Cozaar (

    14、losartan),Examples of ARBs,Atacand (candesartan) Cozaar (losartan) Diovan (valsartan) Micardia (telmisartan) Benicar (olmesartan),Antiadrenergics,Inhibit activity of the sympathetic nervous system Effective in decreasing heart rate, force of myocardial contraction, cardiac output, and blood pressure

    15、,Antiadrenergics,Alpha 1 adrenergics receptor blocking agents dilate vessels and decrease peripheral vascular resistance Can experience first dose phenomenon with orthostatic hypotension, dizziness, syncope, possible sodium and fluid retention,Antiadrenergics-Alpha 1,Cardura (doxazosin) Minipress (p

    16、razosin) Hytrin (terazosin),Antiadrenergics,Centrally acting sympatholytics stimulate presynaptic alpha 2 receptors in the brain Less norepinephrine is released and sympathetic outflow is reduced Results in decreased cardiac output, heart rate, peripheral vascular resistance and blood pressure,Antia

    17、drenergicsAlpha 2 agonists,Centrally acting agents also can result in fluid and sodium retention Catapres (clonidine)orally or by patch Tenex (guanfacine) Aldomet (methyldopa),Beta Adrenergic Blockers,Decrease heart rate, force of myocardial contraction, cardiac output, and renin release from the ki

    18、dneys Drugs of choice with patients with tachycardia, angina, MI, left ventricular hypertrophy and high renin hypertension Most are pregnancy category C and D,Beta Blockers,Inderal (propranolol) Corgard (nadolol) Lopressor (metoprolol) Tenormin (atenolol) Kerlone (betaxolol) for glaucoma (ophthalmic

    19、), hypertension (orally),Calcium Channel Blocking Agents,Useful in hypertension as dilate peripheral arteries and decrease peripheral vascular resistance by relaxing vascular smooth muscle Monotherapy or in combination Tolerated well in renal failure,Calcium Channel Blocking Agents,Norvasc (amlodipi

    20、ne) Cardizem (diltiazem) Plendil (felodipine) Procardia (nifedipine) Calan (verapamil)may cause gingival hyperplasia Note these are also Pregnancy category C,Diuretics,Useful in hypertension due to their sodium and water depletion May be used as monotherapy Preferred in the elderly and in African-Am

    21、ericans Should be included in any multi-drug regimen Thiazide diuretics are most commonly used diuretics for hypertension,Diuretics,Hydrodiuril (HCTZ),Vasodilators,Relax smooth muscle in blood vessels resulting in dilation and decreased peripheral vascular resistance Reduce afterload so helpful in h

    22、eart failure May cause sodium and water retention,Vasodilators,Limited effect when used alone. Vasodilating action that lowers BP also stimulates SNS. This, in turn, triggers reflexive compensatory mechanisms that raise BP,Vasodilators,Corlopam (felodapam)IV infusion, in hypertensive emergencies, av

    23、oid in patients with allergies to sulfites Apresoline (hydralazine)IV, IM or PO. Can cause orthostatic hypotension. Rogaine (Minoxidil) po or topical,Ethnic Considerations,Use calcium channel blockers, diuretics and alpha blockers most effective in African Americans; beta blockers, ACEIs and some AR

    24、Bs are not as effective as in Caucasians Beta blockers have greater effects on Asians than in Caucasians,Hypertensive Emergencies,Is defined as having end organ damage or diastolic BP of 120 torr or higher With oral medications, use captopril 25-50mg po every 1 to 2 hours or clonidine , 0.2mg initia

    25、lly then 0.1mg every hour until diastolic blood pressure falls below 110 torr or 0.7mg has been given,Hypertensive Emergencies,Nitroglycerinetolerance develops over 24-48 hours Nitroprussideintraarterial bood pressure should be monitored; metabolized to thiocyanate (precursor to cyanide), a toxic me

    26、tabolite. Measure serum levels if drug given over 72h. Is photosensitive.,Hypertensive Emergencies,Corlopam (felodopam)IV infusion, use short term.,Herbals that affect BP,Ephedra (ma huang) Gingseng Yohimbe (for erectile dysfunction) caffeine,In regards to anti-hypertensives, should not abruptly sto

    27、p any of them. May develop rebound hypertension.,Diuretics,Indicated for the treatment of edematous and nonedematous conditions May be useful in preventing renal failure by sustaining urine flow A minimum daily urine output of approx. 400ml is required to remove normal amounts of metabolic end produ

    28、cts,Diuretics,Act on kidneys to decrease absorption of sodium, chloride, water and other substances such as calcium Major subclasses are: thiazides, loop and potassium-sparing diuretics Each act at different sites of the nephron,Diuretics,Used to manage: Edema and ascites Management of heart failure

    29、 Hypertension,Thiazide Diuretics,Chemically related to sulfonamides so caution with sulfa allergies Used in long term management of heart failure and hypertension Affect distal convoluted tubule Effectiveness decreases as the GFR decreases. Ineffective when GFR is 30mL/minute. As rising creatinine n

    30、oted, should use alternative such as loop diuretic.,Thiazide Diuretics,Diuril (chlorothiazide) Hygroton (chlorthalidone) HydroDIURIL (hydrochlorothiazide),Loop Diuretics,Inhibit sodium and chloride reabsorption in the ascending limb of the Loop of Henle Potent diuresis Need to restrict dietary sodiu

    31、m when taking these meds Lasix (furosemide) is the prototype,Loop Diuretics,Bumex (bumetamide) more potent than Lasix Can give either as oral agents, IV or IM Rapid administration can cause deafness Must monitor potassium levels, I&0, also weight would be optimum,Potassium Sparing Diuretics,Act at d

    32、istal tubule to decrease reabsorption of sodium and potassium excretion Spironolactone (prototype) blocks the sodium retaining effects of aldosterone Weak diuretics when used alone, often used in combination Contraindicated in renal failure,Osmotic Diuretics,Produce rapid diuresis by increasing the

    33、solute load of the glomerular filtrate Water is pulled into the intravascular space and excreted via kidneys Useful in managing oliguria or anuria Can prevent acute renal failure during prolonged surgery, trauma or during chemotherapy,Osmotic Diuretics,Help reduce increased ICP, reduction of intraoc

    34、ular pressure before certain ophthalmic surgery and for urinary excretion of toxic substances Examples include: Osmitrol (mannitol), Ismotic (isosorbide) and Osmoglyn (glycerin),Drugs that affect Coagulation,Thrombosis may occur in both arteries and veins Arterial thrombi cause disease by obstructin

    35、g blood flow which can result in tissue ischemia or death Venous thrombosis is associated with venous stasis. A venous thrombus is less cohesive than an arterial embolus so venous emboli more prevalent,Hemostasis,Hemostasis is the prevention or stoppage of blood loss from an injured blood vessel. Pr

    36、ocess involves vasoconstriction, formation of a platelet plug, activation of clotting factors and growth of fibrous tissue into the blood clot making it more stable.,Clot Lysis,When clot is being formed, plasminogen is bound to fibrin and becomes a component of the clot After tear in blood vessel is

    37、 repaired, plasminogen is activated by plasminogen activator to produce plasmin. Plasmin (enzyme) breaks down the fibrin mesh and dissolves the clot.,Blood Coagulation Factors,I fibrinogen II prothrombin Ill thromboplastin IV calcium V Labile factor VII proconvertin or stable factor VIII antihemophi

    38、lic factor IX Christmas factor X Stuart factor XI plasma thromboplastin antecedent XII Hageman factor XIII fibrin-stabilizing factor,Anticoagulants,Given to prevent formation of new clots and extension of clots already present; do not dissolve clots already present Prototype is Heparin Heparin may b

    39、e used in pregnancy Weight based dosing per institutional nomogram,Heparin,Usually will give a loading dose then calculated dosage per 24h; e.g. 15-25units/kg/h for IV dosing Monitor aPTT, should be 1.5-2.5 control valuenormal value is 35 sec. Can cause heparin induced thrombocytopenia Reversal agen

    40、t is protamine sulfate,Heparin,Combines w/antithrombin III which will inactivate clotting factors IX, X, XI and XII, inhibits conversion of prothrombin to thrombin and prevents thrombus formation. Further affects coagulation by preventing conversion of fibrinogen to fibrin, inhibiting factors V,VIII

    41、, XIII and platelet aggregation.,Low Molecular Weight Heparins,Given subcutaneously in abdomen and do not require close monitoring of blood coagulation tests Still should follow platelet counts Fragmin (dalteparin) Lovenox (enoxaparin),Coumadin (warfarin),Most commonly used oral anticoagulant Drug a

    42、cts in liver to prevent synthesis of vitamin K-dependent clotting factors (II,VII,IX, X). Acts as a competitive antagonist to hepatic use of vitamin K. Anticoagulant of choice for long-term maintenance therapy.,Coumadin (warfarin),Anticoagulant effects do not occur for 3-5 days after warfarin is sta

    43、rted Has no effect on platelets or on circulating clotting factors Regulated according to the INR (international normalized ratio) . Therapeutic values are generally 2 to 3.,Coumadin,INR is based on prothrombin time. Normal baseline or control PT is 12 seconds, therapeutic value is 1.5 times the con

    44、trol or 18 seconds. Use of INR has eliminated disparities in different labs,Coumadin,Dosage reduction in patients with biliary tract disorders, liver disease, malabsorption syndromes, and hyperthyroidism. These conditions increase anticoagulant drug effects by reducing absorption of vitamin K or dec

    45、reasing hepatic synthesis of clotting factors Has multiple, multiple drug interactions Counteract with vitamin K,Other anticoagulants,Orgaran (danaparoid)low molecular weight, heparin-like drug. Given subq. Used in management of hip surgery, ischemic stroke or in those who cannot take heparin. Does

    46、not contain heparin. Refludan (lepirudin)used as heparin substitutes Arixtra (fondaparinux) binds to clot bound factor Xa, inhibits thrombon productions,Other Anticoagulants cont. Trade and generic names,Refludan (lepirudin) Argatroban (same generic name) Arixtra (fondaparinux) Angiomax (bivalirudin

    47、),Antiplatelet Drugs,Arterial thrombi are composed primarily of platelets Antiplatelet drugs act by inhibiting platelet activation, adhesion, aggregation, or procoagulant activity. Include drugs that block platelet receptors for thromboxane, ADP, glycoprotein IIb/IIIa and phosphodiesterase inhibitor

    48、s,Thromboxane A2 Inhibitors,Work by inhibiting synthesis of prostaglandins. TA inhibitors work by acetylating cyclooxygensase, the enzyme in platelets that synthesizes thromboxane A2 (which causes platelet aggregation). ASA is example. It affects the platelets for the life of the platelet. NSAIDs no

    49、t so useful as action wears off as drug wears off,Adenosine Diphosphate Receptor Antagonists,Ticlid (ticlopidine) Inhibit platelet aggregation by preventing ADP-induced binding between platelets and fibrinogen. This reaction inhibits platelet aggregation irreversibly and persist for the lifespan of

    50、the platelet (9-10 days) Indicated in TIAs Adverse effects-neutropenia, diarrhea, skin rashes,Adenosine Diphosphate Receptor Antagonists,Plavix (clopidogrel) Fewer side effects than ASA or Ticlid indicated for patients with atherosclerosis for reduction of MI, stroke and vascular death Does not need reduction in those with renal problems,


    注意事项

    本文(ANTIHYPERTENSIVES, DIURETICS, ANTICOAGULANTS .ppt)为本站会员(appealoxygen216)主动上传,麦多课文档分享仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对上载内容本身不做任何修改或编辑。 若此文所含内容侵犯了您的版权或隐私,请立即通知麦多课文档分享(点击联系客服),我们立即给予删除!




    关于我们 - 网站声明 - 网站地图 - 资源地图 - 友情链接 - 网站客服 - 联系我们

    copyright@ 2008-2019 麦多课文库(www.mydoc123.com)网站版权所有
    备案/许可证编号:苏ICP备17064731号-1 

    收起
    展开